Cita APA

AB, G., S, S., ML, C., ÁL, G., P, I., JM, L., . . . P, P. (2019). Evidence and experience with onabotulinumtoxinA in chronic migraine: Recommendations for daily clinical practice.

Citación estilo Chicago

AB, Gago-Veiga, et al. Evidence and Experience With OnabotulinumtoxinA in Chronic Migraine: Recommendations for Daily Clinical Practice. 2019.

Cita MLA

AB, Gago-Veiga, et al. Evidence and Experience With OnabotulinumtoxinA in Chronic Migraine: Recommendations for Daily Clinical Practice. 2019.